Does IDECABTAGENE VICLEUCEL Cause Malignant neoplasm progression? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with IDECABTAGENE VICLEUCEL (Abecma). This represents 0.5% of all adverse event reports for IDECABTAGENE VICLEUCEL.
5
Reports of Malignant neoplasm progression with IDECABTAGENE VICLEUCEL
0.5%
of all IDECABTAGENE VICLEUCEL reports
1
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From IDECABTAGENE VICLEUCEL?
Of the 5 reports, 1 (20.0%) resulted in death, 2 (40.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IDECABTAGENE VICLEUCEL. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does IDECABTAGENE VICLEUCEL Cause?
Cytokine release syndrome (607)
Immune effector cell-associated neurotoxicity syndrome (176)
Fatigue (159)
Neurotoxicity (70)
Neutropenia (68)
Pyrexia (67)
Anaemia (63)
Decreased appetite (54)
Headache (54)
Hypogammaglobulinaemia (54)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which IDECABTAGENE VICLEUCEL Alternatives Have Lower Malignant neoplasm progression Risk?
IDECABTAGENE VICLEUCEL vs IDELALISIB
IDECABTAGENE VICLEUCEL vs IDURSULFASE
IDECABTAGENE VICLEUCEL vs IFOSFAMIDE
IDECABTAGENE VICLEUCEL vs IGURATIMOD
IDECABTAGENE VICLEUCEL vs ILOPERIDONE